Xeris Biopharma Holdings Inc. buy Oppenheimer Holdings Inc.
Start price
28.03.24
/
50%
€2.04
Target price
28.03.25
€4.62
Performance (%)
-16.52%
Price
03.05.24
€1.75
Summary
This prediction is currently active. The price of Xeris Biopharma Holdings Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.52%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Xeris Biopharma Holdings Inc. | 7.419% | 7.419% |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $5.00 price target on the stock.
Ratings data for XERS provided by MarketBeat